Pictet Asset Management Holding SA »

Adma Biologics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $207k 31k 6.60

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Adma Biologics

BlackRock
Vanguard Group
Nuveen Asset Management
American Century Companies
Perceptive Advisors
AWM Investment Company
D. E. Shaw & Co
Geode Capital Management
Two Sigma Investments
Morgan Stanley
Dimensional Fund Advisors
Two Sigma Advisers
Ophir Asset Management Pty
Assenagon Asset Management
Deutsche Bank Aktiengesellschaft

View all funds holding Adma Biologics